Eurofins Scientific SE (ERFSF)
USD 49.72
(0.0%)
USD 49.72
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.23 Billion EUR | -36.25% |
| 2022 | 857.7 Million EUR | -31.97% |
| 2021 | 1.26 Billion EUR | 39.12% |
| 2020 | 906.3 Million EUR | 114.81% |
| 2019 | 421.9 Million EUR | 25.0% |
| 2018 | 337.51 Million EUR | 17.43% |
| 2017 | 287.41 Million EUR | 1.94% |
| 2016 | 281.94 Million EUR | 113.02% |
| 2015 | 132.35 Million EUR | 30.62% |
| 2014 | 101.33 Million EUR | 13.78% |
| 2013 | 89.06 Million EUR | 9.27% |
| 2012 | 81.5 Million EUR | -10.19% |
| 2011 | 90.75 Million EUR | 86.31% |
| 2010 | 48.71 Million EUR | 38.36% |
| 2009 | 35.2 Million EUR | -16.06% |
| 2008 | 41.94 Million EUR | 9.43% |
| 2007 | 38.32 Million EUR | 2.72% |
| 2006 | 37.31 Million EUR | 25.46% |
| 2005 | 29.74 Million EUR | 110.06% |
| 2004 | 14.15 Million EUR | 93.18% |
| 2003 | 7.32 Million EUR | 52.94% |
| 2002 | 4.79 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 699 Million EUR | 0.0% |
| 2023 Q2 | 266.89 Million EUR | 0.0% |
| 2023 FY | 546.8 Million EUR | -36.25% |
| 2023 Q4 | 279.9 Million EUR | 0.0% |
| 2022 Q4 | 290.4 Million EUR | 0.0% |
| 2022 FY | 857.7 Million EUR | -31.97% |
| 2022 Q2 | 492.8 Million EUR | 0.0% |
| 2021 FY | 1.26 Billion EUR | 39.12% |
| 2021 Q2 | 729.8 Million EUR | 0.0% |
| 2021 Q4 | 539.8 Million EUR | 0.0% |
| 2020 Q4 | 602.3 Million EUR | 0.0% |
| 2020 FY | 906.3 Million EUR | 114.81% |
| 2020 Q2 | 203.2 Million EUR | 0.0% |
| 2019 Q2 | 132.15 Million EUR | 0.0% |
| 2019 FY | 421.9 Million EUR | 25.0% |
| 2019 Q4 | 234.44 Million EUR | 0.0% |
| 2018 Q2 | 185.78 Million EUR | 0.0% |
| 2018 FY | 337.51 Million EUR | 17.43% |
| 2018 Q4 | 245.01 Million EUR | 0.0% |
| 2017 Q2 | 164.83 Million EUR | 0.0% |
| 2017 Q4 | 186.37 Million EUR | 0.0% |
| 2017 FY | 287.41 Million EUR | 1.94% |
| 2016 Q2 | 140.5 Million EUR | 0.0% |
| 2016 Q4 | 178.75 Million EUR | 0.0% |
| 2016 FY | 281.94 Million EUR | 113.02% |
| 2015 FY | 132.35 Million EUR | 30.62% |
| 2015 Q2 | 82.44 Million EUR | 0.0% |
| 2015 Q4 | 151.46 Million EUR | 0.0% |
| 2014 FY | 101.33 Million EUR | 13.78% |
| 2014 Q4 | 105.55 Million EUR | 0.0% |
| 2014 Q2 | 69.1 Million EUR | 0.0% |
| 2013 Q4 | 69.62 Million EUR | 0.0% |
| 2013 Q2 | 66.18 Million EUR | 0.0% |
| 2013 FY | 89.06 Million EUR | 9.27% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 FY | 81.5 Million EUR | -10.19% |
| 2011 Q1 | 6.31 Million EUR | -87.69% |
| 2011 Q4 | 34.49 Million EUR | 20.91% |
| 2011 Q2 | 23.04 Million EUR | 264.73% |
| 2011 Q3 | 28.52 Million EUR | 23.82% |
| 2011 FY | 90.75 Million EUR | 86.31% |
| 2010 Q1 | 687 Thousand EUR | -94.64% |
| 2010 Q2 | 13.43 Million EUR | 1855.31% |
| 2010 Q3 | 53.67 Million EUR | 299.55% |
| 2010 Q4 | 51.31 Million EUR | -4.4% |
| 2010 FY | 48.71 Million EUR | 38.36% |
| 2009 FY | 35.2 Million EUR | -16.06% |
| 2009 Q4 | 12.82 Million EUR | -67.76% |
| 2009 Q3 | 39.78 Million EUR | 518.52% |
| 2009 Q1 | 1.66 Million EUR | 0.0% |
| 2009 Q2 | 6.43 Million EUR | 285.38% |
| 2008 FY | 41.94 Million EUR | 9.43% |
| 2007 FY | 38.32 Million EUR | 2.72% |
| 2006 FY | 37.31 Million EUR | 25.46% |
| 2005 FY | 29.74 Million EUR | 110.06% |
| 2004 FY | 14.15 Million EUR | 93.18% |
| 2003 FY | 7.32 Million EUR | 52.94% |
| 2002 FY | 4.79 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | 99858.454% |
| Arrayit Corporation | -3.62 Million USD | 34302.729% |
| Atlantic International Corp. | -5.73 Million USD | 21713.573% |
| Biocept, Inc. | -31.98 Million USD | 3973.933% |
| Bioqual, Inc. | -19.63 Thousand USD | 6309296.456% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | 160562.713% |
| DermTech, Inc. | -103.73 Million USD | 1294.343% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 50.18% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 6048.267% |
| iMD Companies, Inc. | -175.44 Thousand USD | 706300.198% |
| IDenta Corp. | -1499.00 USD | 82655203.402% |
| Interpace Biosciences, Inc. | 2.8 Million USD | -44086.876% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -3202277.875% |
| InVitro International | -25.33 Thousand USD | 4889795.726% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 17496.799% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 2132189.758% |
| Medical Imaging Corp. | -819.48 Thousand USD | 151293.44% |
| NovelStem International Corp. | -3.52 Million USD | 35240.971% |
| Optigenex Inc. | 1.39 Million USD | -88983.177% |
| PharmChem, Inc. | 973.14 Thousand USD | -127218.894% |
| Proteome Sciences plc | -1.62 Million USD | 76534.3% |
| Response Genetics, Inc | -21.37 Million USD | 5895.949% |
| Rennova Health, Inc. | -1.4 Million USD | 88001.392% |
| RushNet, Inc. | -684.7 Thousand USD | 181053.841% |
| ScreenPro Security Inc. | -2.59 Million USD | 47893.034% |
| Stella Diagnostics Inc. | -11.42 Million USD | 10942.788% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 16093.781% |
| Todos Medical Ltd. | -9.74 Million USD | 12810.3% |